Vidcast:  https://youtu.be/QqX4vyzngIk

 

The shortage of the available Danish monkeypox vaccine Jynneos has driven the CDC to recommend vaccination with one-fifth the originally recommended dose injected between the layers of the skin rather than beneath the skin.  Some scientists are pushing back on the plan claiming that the so-called intradermal vaccination route is not as effective.

 

The literature pushes back on this notion.  As early as 1980, a Swedish study on the typhoid vaccine showed that the intradermal route generated comparable protective antibody titers when compared with the subcutaneous route.  The added benefits of intradermal vaccinations: 7.5 fold lower incidence of local skin and general febrile reactions as well as a 3.7 fold lower incidence of severe local skin reactions.

 

More recently, in 2004, Dr. Anthony Fauci himself co-authored a New England Journal article about stretching available doses of flu vaccine using a smaller dose of vaccine administered intradermally rather than intramuscularly.  He points out that intradermal vaccination may actually induce a stronger immune response than intramuscular vaccination when used for not only flu vaccinations but also for those against hepatitis B, rabies, and other infectious disease,

 

If you need a monkeypox vaccination, get the intradermal jab.  If you can’t get the vaccine, protect yourself with hygenic sexual practices, avoiding contact with those demonstrating skin rashes, and us hand and surface cleansing using disinfectants and go ol’ 70% isopropyl alcohol.

 

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/5612191EDC16CF79A2B2C88B6FBA4ABE/S0022172400026462a.pdf/intradermal-versus-subcutaneous-immunization-with-typhoid-vaccine.pdf

https://www.nejm.org/doi/full/10.1056/NEJMe048314

 

#monkeypox #vaccination #intradermal #subcutaneous